intravitreal injection
Optometry’s latest move for expanded scope
In a new push for expanded scope-of-practice, Optometry Australia is calling for change in six areas – including oral medications ...
MBS Taskforce keeps controversial eye injection proposals in final report
Despite vehement opposition from ophthalmologists, the MBS Taskforce has forged ahead with plans to cut the rebate for intravitreal injections ...
Aged care policies proving a major barrier for patients
Blanket policies in aged-care facilities, including complete lockdowns and two-week quarantines for residents who seek external medical treatment, have been ...
Ita Buttrose fronts new eye injections TV campaign
Macular Disease Foundation Australia (MDFA) has launched a series of community service announcements featuring national icon Ms Ita Buttrose in ...
Questions over economic viability of MBS proposals
Proposed cuts to the rebate and fee for intravitreal injections will impact bulk billing services and access to treatment, Australia’s ...
Novartis secures approval for AMD drug in Australia
Australia’s ophthalmic community has welcomed the approval of Novartis’ latest therapy for neovascular age-related macular degeneration (nAMD). Advocates hope the ...
Government pushes ocular projects for commercial development
Projects to develop decision support software for macular disease, sustained release ocular implants and a control sleeve for intravitreal injections ...
Latest eye injection proposals draw sharp rebuke from ophthalmology
Controversial plans to dramatically reduce the rebate for intravitreal injections and also allow non-ophthalmologists to perform the procedure have divided ...